Omega Therapeutics Inc. (NASDAQ: OMGA)
$2.09
+0.1350 ( +6.92% ) 360.7K
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. ItĀ operates in the U.S.
Market Data
Open
$2.09
Previous close
$1.95
Volume
360.7K
Market cap
$115.27M
Day range
$1.98 - $2.14
52 week range
$1.30 - $6.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 11, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
10-q | Quarterly Reports | 80 | Nov 09, 2023 |
8-k | 8K-related | 36 | Sep 26, 2023 |
8-k | 8K-related | 13 | Sep 22, 2023 |
3 | Insider transactions | 2 | Aug 29, 2023 |
4 | Insider transactions | 1 | Aug 29, 2023 |
8-k | 8K-related | 13 | Aug 29, 2023 |
10-q | Quarterly Reports | 84 | Aug 03, 2023 |
8-k | 8K-related | 18 | Aug 03, 2023 |